CJC NO DAC+IPA

CJC NO DAC+IPA

Categories:

CJC NO DAC+IPA 10MG is a synthetic research peptide formulation combining a growth hormone-releasing hormone (GHRH) analog with ipamorelin, a peptide studied in biochemical and endocrine research. This product is intended strictly for scientific investigation of peptide-mediated signaling and cellular responses within controlled laboratory environments.

$45.00

30 in stock

30 in stock

Spec Conformance

Secure
Payment

Third-party
Tested

CJC NO DAC+IPA

CJC NO DAC+IPA 10MG is a synthetic research peptide formulation combining a growth hormone-releasing hormone (GHRH) analog with ipamorelin, a peptide studied in biochemical and endocrine research. This product is intended strictly for scientific investigation of peptide-mediated signaling and cellular responses within controlled laboratory environments.

Research Context

CJC-1295 without DAC and ipamorelin have been investigated in laboratory research for their interactions with GHRH-related and growth hormone secretagogue receptor (GHSR) signaling pathways. Research commonly examines receptor-mediated signaling, intracellular communication, peptide activity, and coordinated molecular responses under controlled experimental conditions.

Research Overview

Research involving CJC NO DAC+IPA commonly examines GHRH-associated signaling, ghrelin receptor-related pathways, peptide-receptor interactions, endocrine signaling mechanisms, and compound-specific molecular behavior. These investigations contribute to a broader understanding of peptide signaling, receptor biology, and cellular regulatory networks in experimental research models.

Key Research Focus Areas

  • GHRH Receptor Research: Investigation of GHRH-related receptor interactions and associated downstream signaling pathways.
  • Growth Hormone Secretagogue Research: Study of ipamorelin-associated interactions with growth hormone secretagogue receptors and related cellular signaling.
  • Endocrine Signaling Studies: Evaluation of peptide-mediated communication within endocrine and cellular regulatory systems.
  • Peptide Interaction Research: Examination of combined peptide activity, receptor interactions, stability, and molecular behavior in experimental systems.
  • Laboratory Formulation: Evaluation of compound stability, compatibility, storage, and handling under standardized research protocols.

Important Compliance and Safety Information

This product is intended strictly for research purposes and must only be handled by qualified professionals in controlled laboratory environments.

For research use only. Not for human or animal consumption.

CJC NO DAC+IPA 10MG is a synthetic research peptide formulation combining a growth hormone-releasing hormone (GHRH) analog with ipamorelin, a peptide studied in biochemical and endocrine research. This product is intended strictly for scientific investigation of peptide-mediated signaling and cellular responses within controlled laboratory environments.
Lab Report
View Report

Research Use Disclaimer

Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.

CJC NO DAC+IPA

CJC NO DAC+IPA 10MG is a synthetic research peptide formulation combining a growth hormone-releasing hormone (GHRH) analog with ipamorelin, a peptide studied in biochemical and endocrine research. This product is intended strictly for scientific investigation of peptide-mediated signaling and cellular responses within controlled laboratory environments.

Research Context

CJC-1295 without DAC and ipamorelin have been investigated in laboratory research for their interactions with GHRH-related and growth hormone secretagogue receptor (GHSR) signaling pathways. Research commonly examines receptor-mediated signaling, intracellular communication, peptide activity, and coordinated molecular responses under controlled experimental conditions.

Research Overview

Research involving CJC NO DAC+IPA commonly examines GHRH-associated signaling, ghrelin receptor-related pathways, peptide-receptor interactions, endocrine signaling mechanisms, and compound-specific molecular behavior. These investigations contribute to a broader understanding of peptide signaling, receptor biology, and cellular regulatory networks in experimental research models.

Key Research Focus Areas

  • GHRH Receptor Research: Investigation of GHRH-related receptor interactions and associated downstream signaling pathways.
  • Growth Hormone Secretagogue Research: Study of ipamorelin-associated interactions with growth hormone secretagogue receptors and related cellular signaling.
  • Endocrine Signaling Studies: Evaluation of peptide-mediated communication within endocrine and cellular regulatory systems.
  • Peptide Interaction Research: Examination of combined peptide activity, receptor interactions, stability, and molecular behavior in experimental systems.
  • Laboratory Formulation: Evaluation of compound stability, compatibility, storage, and handling under standardized research protocols.

Important Compliance and Safety Information

This product is intended strictly for research purposes and must only be handled by qualified professionals in controlled laboratory environments.

For research use only. Not for human or animal consumption.

Sizes

10 MG, 20 MG

Related Compounds

Related products